Charles Burdet

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Takaki Asano, Bertrand Boisson, Fanny Onodi et al. · Science Immunology · 2021 · 410 citations · Full text

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Protection of the Human Gut Microbiome From Antibiotics

Jean de Gunzburg, Amine Ghozlane, Annie Ducher et al. · The Journal of Infectious Diseases · 2017 · 158 citations · Full text

Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia

Guillaume Voiriot, Benoît Visseaux, Johana Cohen et al. · Critical Care · 2016 · 153 citations · Full text

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 153 citations

Community-acquired Pneumonia, Critical Care Medicine, Antibiotics +7